Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 102.38 USD 0.55% Market Closed
Market Cap: 20.3B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ZBH Price Targets Summary
Zimmer Biomet Holdings Inc

Wall Street analysts forecast ZBH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZBH is 123.67 USD with a low forecast of 106.05 USD and a high forecast of 156.57 USD.

ZBH Lowest Forecast
Wall Street Target
106.05 USD
4% Upside
ZBH Average Forecast
Wall Street Target
123.67 USD
21% Upside
ZBH Highest Forecast
Wall Street Target
156.57 USD
53% Upside
Lowest
Price Target
106.05 USD
4% Upside
Average
Price Target
123.67 USD
21% Upside
Highest
Price Target
156.57 USD
53% Upside
Zimmer Biomet Holdings Inc Competitors:
Price Targets
IRTC
iRhythm Technologies Inc
1% Upside
BFLY
Butterfly Network Inc
119% Upside
EW
Edwards Lifesciences Corp
7% Upside
ELN
El En SpA
34% Upside
IRTC
iRhythm Technologies Inc
1% Upside
BFLY
Butterfly Network Inc
119% Upside
EW
Edwards Lifesciences Corp
7% Upside
ELN
El En SpA
34% Upside
B
BBNX
Beta Bionics Inc
122% Upside
O
OBI
Ondine Biomedical Inc
523% Upside
S
688212
Shanghai Aohua Photoelectricity Endoscope Co Ltd
34% Upside
6951
JEOL Ltd
71% Upside

Revenue
Forecast

Revenue Estimate
Zimmer Biomet Holdings Inc

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's revenue is 0%. The projected CAGR for the next 3 years is 4%.

0%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Zimmer Biomet Holdings Inc

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's operating income is 2%. The projected CAGR for the next 3 years is 17%.

2%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-39%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Zimmer Biomet Holdings Inc

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's net income is 15%. The projected CAGR for the next 3 years is 29%.

15%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-43%
Average Miss
What are analyst estimates?

See Also

Summary
ZBH intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZBH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZBH stock valuation using valuation multiples.
Wall Street Estimates
ZBH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZBH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZBH's stock price target?
Price Target
123.67 USD

According to Wall Street analysts, the average 1-year price target for ZBH is 123.67 USD with a low forecast of 106.05 USD and a high forecast of 156.57 USD.

What is Zimmer Biomet Holdings Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's revenue is 0%. The projected CAGR for the next 3 years is 4%.

What is Zimmer Biomet Holdings Inc's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's operating income is 2%. The projected CAGR for the next 3 years is 17%.

What is Zimmer Biomet Holdings Inc's Net Income forecast?
Projected CAGR
29%

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's net income is 15%. The projected CAGR for the next 3 years is 29%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 252,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.